Siddiqi, Z. A. Et Al. 2021. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. Muscle and Nerve , vol.64, no.6 , 662-669.

Siddiqi, Z. A., Nowak, R. J., Mozaffar, T., O'Brien, F., Yountz, M., Patti, F., ... Mazia, C. G.(2021). Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. Muscle and Nerve , vol.64, no.6, 662-669.

Siddiqi, Zaeem Et Al. "Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study," Muscle and Nerve , vol.64, no.6, 662-669, 2021

Siddiqi, Zaeem A. Et Al. "Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study." Muscle and Nerve , vol.64, no.6, pp.662-669, 2021

Siddiqi, Z. A. Et Al. (2021) . "Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study." Muscle and Nerve , vol.64, no.6, pp.662-669.

@article{article, author={Zaeem A. Siddiqi Et Al. }, title={Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study}, journal={Muscle and Nerve}, year=2021, pages={662-669} }